“Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer” has been added to your cart. View cart
Article: A-136 THE p.Arg498Cys MUTATION IN THE CYSTEINE RICH DOMAIN OF ADAMTS13 RESULTS IN A SECRETION DEFICIENCY